CD4 and head and neck squamous cell carcinoma: The percentage of CD4+CD25+Foxp3+ cells showed a significant decrease in advanced stages (P = 0.015), similarly, the frequency of CD4+CD25+Foxp3+CD127low/− showed a trend toward decrease in advanced stages of HNSCC (P = 0.059, Fig. 5).